A Prospective, Randomized, Controlled, Study Evaluating the Safety and Effectiveness of EVARREST Sealant Matrix in Controlling Mild or Moderate Hepatic Parenchyma or Soft Tissue Bleeding During Open Abdominal, Retroperitoneal, Pelvic and Thoracic (non-cardiac) Surgery in Paediatric Patients
Latest Information Update: 12 Sep 2023
At a glance
Most Recent Events
- 07 Sep 2022 Status changed from recruiting to completed.
- 14 Jan 2022 This trial has been completed in Belgium (End Date: 12 Nov 2021), according to European Clinical Trials Database record.
- 13 Aug 2021 Planned End Date changed from 31 Jul 2021 to 1 Jul 2022.